IREN
IREN Limited
There isn't enough reported data to score IREN yet.
OZK
Bank OZK
OZK's fundamentals are mixed. At 8.3x earnings, it's trading right at its usual valuation. Analysts expect earnings to hold roughly steady.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
OZK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
OZK's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like OZK.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
OZK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.3x | $44.10 | -13% |
| Current | 8.3x | $50.45 | — |
| Fair | 8.4x | $50.57 | +0.2% |
| Forward | 8.4x | $50.45 | — |
| Expensive | 11x | $67.55 | +34% |
Historical ranges are pointers, not guarantees.
OZK's PE is in its fair range at 8.3x. On analysts' estimates for next year's earnings, today's price would be 8.4x.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
OZK Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect OZK's profitability to weaken, with its earnings and revenue holding steady.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
OZK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.01 | -0.7% |
| Q2 2026 | $6.05 | -1.8% |
| Q1 2026 | $6.14 | +0.7% |
| Q4 2025 | $6.17 | +0.5% |
| Q3 2025 | $6.20 | +2% |
| Q2 2025 | $6.16 | +2.3% |
| Q1 2025 | $6.10 | +2.2% |
| Q4 2024 | $6.14 | +4.6% |
| Q3 2024 | $6.08 | +6.5% |
OZK has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
OZK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $672.9M | -3.8% |
| Q1 2026 | $661.5M | -1.3% |
| Q4 2025 | $704.6M | +1.3% |
| Q3 2025 | $731.1M | +2.2% |
| Q2 2025 | $699.6M | +0.4% |
| Q1 2025 | $670.5M | +0.6% |
| Q4 2024 | $695.6M | +7% |
| Q3 2024 | $715.7M | +21% |
OZK's revenue grew through 2024 and has held roughly level since: $673M last quarter, down 3.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 32% | -2.5 points |
| Q1 2026 | 32% | -1.4 points |
| Q4 2025 | 32% | -1.4 points |
| Q3 2025 | 33% | +0.1 points |
| Q2 2025 | 34% | +1.2 points |
| Q1 2025 | 33% | -1.1 points |
| Q4 2024 | 34% | +0.2 points |
| Q3 2024 | 33% | -4.2 points |
OZK has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
OZK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $189M | +48% |
| Q1 2026 | $212.1M | -12% |
| Q4 2025 | $175.3M | +45% |
| Q3 2025 | $186M | -28% |
| Q2 2025 | $128.1M | -5.4% |
| Q1 2025 | $242.3M | +8% |
| Q4 2024 | $121M | -35% |
| Q3 2024 | $258M | -3.3% |
OZK has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
OZK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -1.2M shares |
| 1 year | -3.6% | -4.1M shares |
| 3 years | -4% | -4.6M shares |
| 5 years | -16% | -20.6M shares |
| Available history | -15% | -19.3M shares |
OZK has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $15.5M |
| Q1 2026 | $60M |
| Q4 2025 | $93.7M |
| Q3 2025 | — |
| Q2 2025 | $50.8M |
| Q1 2025 | $7.1M |
| Q4 2024 | — |
| Q3 2024 | $462,000 |
OZK spent $169M buying back its own shares over the past year, up 190% from the year before.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
OZK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
| Q3 2024 | -2.1x | Net Cash |
OZK has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
OZK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.2 | Neutral |
| Stochastic | 75.3 | Neutral |
OZK's weekly RSI is 54 (neutral) and its Stochastic is 75 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
OZK PE vs Financial Services Sector
| Metric | OZK | Sector median | Relative |
|---|---|---|---|
| PE | 8.3x | 13x | 36% below |
| PE % | 49 | 63 | 14 pts below |
OZK is trading at 8.3x earnings, a 36% discount to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
OZK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.3 | 4.4% above |
| 20 week MA | $49.5 | 1.8% above |
| 50 week MA | $48.5 | 4% above |
| 100 week MA | $47.8 | 5.6% above |
| 200 week MA | $44.9 | 12% above |
OZK has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
OZK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.8 | $31.1 | +1% |
| 2021 | $31.1 | $45.4 | +46% |
| 2022 | $45.4 | $40.3 | -11% |
| 2023 | $40.3 | $49.8 | +24% |
| 2024 | $49.8 | $44.6 | -11% |
| 2025 | $44.6 | $47.2 | +5.8% |
| 2026 YTD | $47.2 | $50.5 | +7% |
OZK has the edge over IREN on returns for 2026, with the stronger performance.